Key facts
- Cardio Intelligence’s last known valuation is $17.4M (Aug 2022).
- It has raised $6.7M; the latest was Later Stage VC in Mar 2026.
- Notable investors include SMBC Venture Capital, ANRI, Nissay Capital, Shizuoka Capital, Daiwa Corporate Investment — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Cardio Intelligence
- ·The full record, as it builds
Funding rounds
No funding rounds for Cardio Intelligence are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cardio Intelligence
Developer of an artificial intelligence-based diagnosis support system designed to detect atrial fibrillation at an early stage. The company's system offers an automated analysis with the help of electrocardiogram data, enabling healthcare professionals to deliver diagnoses and treatment for heart diseases.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2019
- Employees
- 20
- Website
- cardio-i.com/
- Ownership
- Privately Held (backing)
Cardio Intelligence doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cardio Intelligence shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cardio Intelligence in its N-PORT filings yet. We sweep new filings monthly.